WT
BMY.RT

Washington Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Washington Trust’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-891
Closed – – 1078
2020
Q4 		$0 Hold
891
– – ﹤0.01% 1066
2020
Q3 		$2K Buy
891
+350
+65% +$1K ﹤0.01% 898
2020
Q2 		$1K Sell
541
-26
-5% -$94 ﹤0.01% 869
2020
Q1 		$3K Buy
+567
New +$1.87K ﹤0.01% 813

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Washington Trust's BMY.RT Position: Q1 2021 in Review

Washington Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 891 shares.

Washington Trust first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $3K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Washington Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Washington Trust sold 891 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Washington Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Washington Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Washington Trust's 13F filing for Q1 2021, filed 28 Apr 2021.